loadpatents
Patent applications and USPTO patent grants for Gibbs; Craig S..The latest application filed is for "use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis".
Patent | Date |
---|---|
Therapeutic phosphonate compounds Grant 7,645,747 - Boojamra , et al. January 12, 2 | 2010-01-12 |
Use of Adefovir or Tenofovir for Inhibiting Mmtv-Like Viruses Involved in Breast Cancer and Primary Biliary Cirrhosis App 20070281911 - Cihlar; Tomas ;   et al. | 2007-12-06 |
Therapeutic phosphonate compounds App 20060264404 - Boojamra; Constantine G. ;   et al. | 2006-11-23 |
Polypeptides and coagulation therapy Grant 7,060,484 - Gibbs , et al. June 13, 2 | 2006-06-13 |
Methods of inhibition of MMTV-like viruses App 20050239753 - Cihlar, Tomas ;   et al. | 2005-10-27 |
Novel polypeptides and coagulation therapy App 20040214280 - Gibbs, Craig S. ;   et al. | 2004-10-28 |
Polypeptides and coagulation therapy Grant 6,110,721 - Gibbs , et al. August 29, 2 | 2000-08-29 |
SEC | 0001614856 | Gibbs Craig S |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.